From the Department of Kidney and Pancreas Transplant, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia and
From the Department of Kidney and Pancreas Transplant, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia and.
QJM. 2015 Oct;108(10):803-11. doi: 10.1093/qjmed/hcv033. Epub 2015 Feb 5.
Significant numbers of kidneys are discarded due to raised terminal creatinine of the donor.
To determine long-term outcomes of kidneys utilized from donors with severe acute kidney injury (AKI).
In this retrospective study, we included all patients who received kidneys from deceased donors between years 2000 and 2012. AKI was defined according to the acute kidney injury network (AKIN) classification. The primary outcomes were patient and graft survival and secondary outcomes were renal function at different time points, delayed graft function, acute rejection and length of hospital stay.
Two hundred and eighty-four recipients received kidneys from 261 deceased donors. One hundred and fourteen patients (40%) received kidneys from the donors with AKI. Forty-two patients received kidneys from the donors with severe AKI (AKIN-3 category). Mean age of the donor and recipient was 36 and 37 years, respectively. Main cause of death in donors was road traffic accident (34%) followed by cerebrovascular accident (33%). Terminal creatinine was 85 and 262 μmol/l in non-AKI and AKI groups, respectively (P < 0.001). Significantly more patients in the AKI group had delayed graft function (P = 0.006), prolonged hospital stay (P < 0.001) and high creatinine at discharge (P = 0.002). However, acute rejection rates (P = 0.25), 1-, 5- and 10-year graft survival (P = 0.57) and patient survival (P = 0.77) were not different between AKI and non-AKI groups. The outcomes in the AKIN-3 category were comparable with the non-AKI group.
This study has shown favorable long-term outcomes of kidneys utilized from donors with severe AKI. This study may encourage healthcare professionals to consider accepting such kidneys.
由于供体终末期肌酐升高,大量肾脏被丢弃。
确定利用严重急性肾损伤(AKI)供体的肾脏的长期结果。
在这项回顾性研究中,我们纳入了 2000 年至 2012 年间所有接受过已故供体肾脏的患者。AKI 根据急性肾损伤网络(AKIN)分类进行定义。主要结局是患者和移植物存活率,次要结局是不同时间点的肾功能、延迟移植物功能、急性排斥反应和住院时间。
284 名受者接受了 261 名已故供者的肾脏。114 名患者(40%)接受了 AKI 供者的肾脏。42 名患者接受了 AKIN-3 期供者的肾脏。供体和受者的平均年龄分别为 36 岁和 37 岁。供体死亡的主要原因是道路交通意外(34%),其次是脑血管意外(33%)。非 AKI 组和 AKI 组的终末期肌酐分别为 85 和 262μmol/L(P < 0.001)。AKI 组明显更多的患者出现延迟移植物功能(P = 0.006)、住院时间延长(P < 0.001)和出院时肌酐升高(P = 0.002)。然而,急性排斥反应率(P = 0.25)、1、5 和 10 年移植物存活率(P = 0.57)和患者存活率(P = 0.77)在 AKI 组和非 AKI 组之间无差异。AKIN-3 期的结果与非 AKI 组相当。
本研究表明,利用严重 AKI 供体的肾脏具有良好的长期结果。本研究可能鼓励医疗保健专业人员考虑接受此类肾脏。